Phase I/II Clinical Trial of the Combination of Trastuzumab (Herceptin) and 17-allylamino-17-demethoxy-geldanamycin (KOS-953; 17-aag)
Phase of Trial: Phase I/II
Latest Information Update: 14 May 2008
At a glance
- Drugs Tanespimycin; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Kosan Biosciences
- 14 May 2008 Updated results will be presented at the American Society of Clinical Oncolgy 2008 meeting, according to a Kosan media release.
- 16 Dec 2007 Preliminary results from 20 clinically evaluable patients were presented at the 2007 San Antonio Breast Cancer Symposium held in San Antonio, Texas, USA.
- 22 Jan 2007 New trial record.